Patients with IBD in rural areas are significantly less likely to receive advanced therapies and multidisciplinary care compared with their urban counterparts.

In a retrospective study, overlapping biologic therapy for ulcerative colitis or Crohn disease did not significantly increase risk of infections.

The Food and Drug Administration has designated Hadlima (adalimumab-bwwd) an interchangeable biosimilar to Humira (adalimumab).

The FDA has granted Fast Track designation to TEV-53408, an investigational anti-interleukin-15 antibody, for the treatment of celiac disease.

For patients with BRAF V600E-mutated metastatic CRC, overall survival significantly longer with encorafenib + cetuximab + chemotherapy.

Hormel Foods is recalling more than 256,000 pounds of its Dinty Moore Beef Stew amid reports that wood fragments were found in some cans.

Federal health officials pulled back a key recommendation that pregnant women get the COVID-19 vaccine, causing sharp criticism from experts.